Current clinical use of intravenous fosfomycin in ICU patients in two European countries
ConclusionOur data suggest that IV fosfomycin is an effective and safe combination partner for the treatment of a broad spectrum of severe bacterial infections in critically ill patients.
Source: Infection - Category: Infectious Diseases Source Type: research
More News: Austria Health | Drugs & Pharmacology | Enterococcus | Gastroenteritis | Germany Health | Infectious Diseases | Intensive Care | Multidrug Resistance | Pneumonia | Study